Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations
โ Scribed by Ui-Soon Khoo; Hextan Y.S. Ngan; Annie N.Y. Cheung; Kelvin Y.K. Chan; Jing Lu; Vivian W.Y. Chan; Susan Lau; Irene L. Andrulis; Hilmi Ozcelik
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 46 KB
- Volume
- 16
- Category
- Article
- ISSN
- 1059-7794
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Germline mutations in the BRCA1 and BRCA2 genes account for the majority of high-risk breast/ovarian cancer families, depending on the population studied. Previously, BRCA1 mutations were described in women from Western Poland. To further characterize the spectrum of BRCA1 mutations and the impact o
Women harboring BRCA1 germline mutations carry an 85% lifetime risk of developing breast cancer and a 63% risk of ovarian cancer. In this first systematic study of familial breast and/or ovarian cancer in Germany we investigated 29 families for germline mutations in the BRCA1 gene. We identified mut
We screened 81 ovarian tumours (30 BRCA1 associated, 18 BRCA2 associated, and 33 sporadic) for somatic TP53 mutations using both DNA analysis and immunostaining. TP53 mutations were significantly more frequent in tumours with mutations in BRCA1 (70% by immunostaining and 60% by DNA analysis) and BRC